CompletedNCT02243878
Stereotactic Radiotherapy for Wet AMD (STAR)
PHASE3 · 411 planned enrolment
- Countries listed
- 1
- Registry update
- August 6, 2025
immortal.lifeTrial registrations containing the exact intervention label 0.5 mg ranibizumab.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 411 planned enrolment
PHASE3 · 986 planned enrolment